SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-24-120235
Filing Date
2024-04-29
Accepted
2024-04-29 08:33:58
Documents
17
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d786954d10ka.htm   iXBRL 10-K/A 421542
2 EX-31.3 d786954dex313.htm EX-31.3 3593
3 EX-31.4 d786954dex314.htm EX-31.4 3591
  Complete submission text file 0001193125-24-120235.txt   704226

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA alrn-20231231.xsd EX-101.SCH 4602
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alrn-20231231_cal.xml EX-101.CAL 675
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alrn-20231231_def.xml EX-101.DEF 18275
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE alrn-20231231_lab.xml EX-101.LAB 24169
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alrn-20231231_pre.xml EX-101.PRE 19519
20 EXTRACTED XBRL INSTANCE DOCUMENT d786954d10ka_htm.xml XML 9914
Mailing Address 12407 N. MOPAC EXPY. SUITE 250 #390 AUSTIN TX 78758
Business Address 12407 N. MOPAC EXPY. SUITE 250 #390 AUSTIN TX 78758 7378021989
Aileron Therapeutics, Inc. (Filer) CIK: 0001420565 (see all company filings)

IRS No.: 134196017 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38130 | Film No.: 24886755
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)